Shigeru Kageyama

Clinical Efficacy of Magnesium Supplementation in Patients with Type 2 Diabetes

Kuninobu Yokota, Mitsutoshi Kato, Frank Lister et al. · Journal of the American College of Nutrition · 2004 · 78 citations

Medicine, Nutrition, Nutritional Sciences +17

Efficacy and Safety of the Selective Aldosterone Blocker Eplerenone in Japanese Patients With Hypertension: A Randomized, Double‐Blind, Placebo‐Controlled, Dose‐Ranging Study

Takao Saruta, Shigeru Kageyama, Toshio Ogihara et al. · Journal of Clinical Hypertension · 2004 · 47 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Comparison of the effects of acarbose and voglibose in healthy subjects

Shigeru Kageyama, Noboru Nakamichi, Hisayuki Sekino et al. · Clinical Therapeutics · 1997 · 46 citations

Medicine, Pharmacokinetics, Pharmacology +8

Ipragliflozin (ASP1941), a selective sodium-dependent glucose cotransporter 2 inhibitor, safely stimulates urinary glucose excretion without inducing hypoglycemia in healthy Japanese subjects

Takeshi Kadokura, Masako Saitō, Atsushi Utsuno et al. · Diabetology International · 2011 · 38 citations

Medicine, Endocrinology, Pharmacology +14

Tolerability, pharmacokinetics and pharmacodynamics of the once-daily human GLP-1 analog liraglutide in Japanese healthy subjects: a randomized, double-blind, placebo-controlled dose-escalation study

S. Irie, Yasuhiro Matsumura, Milan Zdravković et al. · International Journal of Clinical Pharmacology and Therapeutics · 2008 · 38 citations

Pharmacy, Pharmacokinetics, Pharmacology +13